Antisense imaging of epidermal growth factor-induced p21 WAF-1/CIP-1 gene expression in MDA-MB-468 human breast cancer xenografts

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 30, Issue 9, 2003, Pages 1273-1280

  Wang, Judy ^a   Chen, Paul ^a   Mrkobrada, Marko ^a   Hu, Meiduo ^a   Vallis, Katherine A ^b,c   Reilly, Raymond M ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antisense oligonucleotides; Breast cancer; Epidermal growth factor; Indium 111; P21 WAF 1 CIP 1

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; INDIUM 111; PROTEIN P21;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; IMAGING SYSTEM; ISOTOPE LABELING; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INDIUM RADIOISOTOPES; ISOTOPE LABELING; METABOLIC CLEARANCE RATE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDES, ANTISENSE; ORGAN SPECIFICITY; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; WHOLE-BODY COUNTING;

EID: 0141670432     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-003-1134-0     Document Type: Article

References (32)

1. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74:957-968.
2. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993; 362:847-849.
3. 1 arrest and apoptosis. Cancer Res 1994; 54:1169-1174.
4. Waldman T, Zhang Y, Dillehay L, et al. Cell-cycle arrest versus cell death in cancer therapy. Nature Med 1997; 3:1034-1036.
5. Chang F, Syrjanen S, Kurvinen K, Syrjanen K. The p53 tumor suppressor gene as a common cellular target in human carcinogenesis. Am J Gastroenterol 1993; 88:174-186.
6. Hollstein MD, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253:49-53.
7. 2 arrest after DNA damage. Science 1998; 282:1497-1501.
8. Fan Z, Lu Y, Wu XP, Deblasio A, Koff A, Mendelsohn J. Prolonged induction of p21(Cip1/WAF1)/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 cell growth inhibition. J Cell Biol 1995; 131:235-242.
9. Thomas T, Balabhadrapathruni S, Gardner CR, Hong J, Faaland CA, Thomas TJ. Effects of epidermal growth factor on MDA-MB-468 breast cancer cells: alterations in polyamine biosynthesis and the expression of p21/CIP1/WAF1. J Cell Physiol 1999; 179:257-266
10. Filmus J, Pollak MN, Cailleau R, Buick RN. A human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem Biophys Res Commun 1985; 128:898-905.
11. Ohtsubo M, Gamou S, Shimizu N. Antisense oligonucleotide of WAF1 gene prevents EGF-induced cell cycle arrest in A431 cells. Oncogene 1998; 16:797-802.
12. Mousses S, Ozcelik H, Lee PD, Malkin D, Bull SB, Andrulis IL. Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer. Hum Mol Genet 1995; 4:1089-1092.
13. Nucleotide BLAST™. National Center for Biotechnology Information, National Institutes of Health, Bethesda, MD. www.ncbi.nlm.nih.gov/BLAST/
14. Dewanjee MK, Ghafouripour AK, Kapodvanjwala M, et al. Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model. J Nucl Med 1994; 35:1054-1063.
15. Moriyama Y, Nishiguchi S, Tamori A, et al. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma. Clin Cancer Res 2001; 7:1293-1298.
16. InStat® Ver. 3.05, GraphPad software, San Diego, CA.
17. Ho PT, Parkinson DR. Antisense oligonucleotides as therapeutics for malignant diseases. Semin Oncol 1997; 24:187-202.
18. Roh H, Pippin J, Drebin JA. Down-regulation of HER-2/neu expression induces apoptosis in human cancer cells that overexpress HER-2/neu. Cancer Res 2000; 60:560-565.
19. WAF1/CIP1. Anticancer Res 2000; 20:837-842.
20. WAF-1/CIP-1 antisense therapy radiosensitizes human colon cancer by converting growth arrest to apoptosis. Cancer Res 2000; 60:679-684.
21. Holmlund JT, Monia BP, Kwoh TJ, Dorr FA. Toward antisense oligonucleotide therapy for cancer: ISIS compounds in clinical development. Curr Opin Mol Ther 1999; 1:372-385.
22. Webb MS, Zon G. Preclinical and clinical experience of antisense therapy for solid tumors. Curr Opin Mol Ther 1999; 1:458-463.
23. Gauchez AS, Du Moulinet D'Hardemare A, Lunardi J, Vuillez JP, Fagret D. Potential use of radiolabeled antisense oligonucleotides in oncology. Anticancer Res 1999; 19:4989-4997.
24. Hnatowich DJ. Antisense and nuclear medicine. J Nucl Med 1999; 40:693-703.
25. 99mTc. J Nucl Med 1995; 36:2306-2314.
26. Tavitian B, Terrazzino S, Kuhnast B, et al. In vivo imaging of oligonucleotides with positron-ernission tomography. Nature Med 1998; 4:467-471.
27. Loke SL, Stein CA, Zhang XH, et al. Characterization of oligonucleotide transport into living cells. Proc Natl Acad Sci USA 1989; 86:3473-3478.
28. Yakubov LA, Deeva EA, Zarytova VF, et al. Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc Natl Acad Sci USA 1981); 86:6454-6458.
29. Stalteri MA, Mather SJ. Hybridization and cell uptake studies with radiolabelled antisense oligonucleotides. Nucl Med Commun 2001; 22:1171-1179.
30. Zhang Y-M, Liu N, Zhu Z-H, Rusckowski M and Hnatowich DJ. Influence of different chelators (HYNIC, MAG3 and DTPA) on tumor cell accumulation and mouse biodistribution of technetium-99m labeled to antisense DNA. Eur J Nucl Med 2000; 27: 1700-1707.
31. Sokol DL, Zhang X, Lu P, Gewirtz AM. Real time detection of DNA-RNA hybridization in living cells. Proc Natl Acad Sci USA 1998; 95:11538-11543.
32. Agrawal S, Temsamani J, Galbraith W, Tang J. Pharmacokinetics of antisense oligonucleotides. Clin Pharmacokin 1995; 28:7-16.